 - minimise the amount of treatment chemotherapy and surgery for all appropriate low risk patients, who in previous studies have been shown to have an excellent long-term outcome as in the SIOPEN 99.1-2 infant neuroblastoma studies where the overall survival was greater than 97H. Rubie, JCO. 